These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25355596)

  • 21. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY
    Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
    Koziol JA; Zhang JY; Casiano CA; Peng XX; Shi FD; Feng AC; Chan EK; Tan EM
    Clin Cancer Res; 2003 Nov; 9(14):5120-6. PubMed ID: 14613989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of humoral immune responses against tumor antigens.
    Reuschenbach M; von Knebel Doeberitz M; Wentzensen N
    Cancer Immunol Immunother; 2009 Oct; 58(10):1535-44. PubMed ID: 19562338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
    Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
    Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.
    Yi YC; Wang SC; Chao CC; Su CL; Lee YL; Chen LY
    J Clin Lab Anal; 2010; 24(5):357-62. PubMed ID: 20872572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
    Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
    Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
    Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY
    Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
    Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.
    Hoshino I; Nagata M; Takiguchi N; Nabeya Y; Ikeda A; Yokoi S; Kuwajima A; Tagawa M; Matsushita K; Satoshi Y; Hideaki S
    Cancer Sci; 2017 Mar; 108(3):308-315. PubMed ID: 28064445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
    Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
    Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens.
    Shi FD; Zhang JY; Liu D; Rearden A; Elliot M; Nachtsheim D; Daniels T; Casiano CA; Heeb MJ; Chan EK; Tan EM
    Prostate; 2005 May; 63(3):252-8. PubMed ID: 15538718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
    Piura E; Piura B
    J Oncol; 2011; 2011():982425. PubMed ID: 21423545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
    Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY
    Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha 2HS-glycoprotein, a tumor-associated antigen (TAA) detected in Mexican patients with early-stage breast cancer.
    Fernández-Grijalva AL; Aguilar-Lemarroy A; Jave-Suarez LF; Gutiérrez-Ortega A; Godinez-Melgoza PA; Herrera-Rodríguez SE; Mariscal-Ramírez I; Martínez-Velázquez M; Gawinowicz MA; Martínez-Silva MG; Cruz-Ramos JA; Hernández-Gutiérrez R
    J Proteomics; 2015 Jan; 112():301-12. PubMed ID: 25106788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.